Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2023 | 10-2022 | 10-2021 | 10-2020 | 10-2019 | |
| Sales | 53,910 | 27,745 | 13,557 | 7,470 | 6,577 |
| Cost of Goods | 40,833 | 21,464 | 9,602 | 6,089 | 5,176 |
| Gross Profit | 13,077 | 6,281 | 3,955 | 1,381 | 1,401 |
| Operating Expenses | 30,305 | 25,391 | 16,648 | 5,681 | 5,138 |
| Operating Income | -17,228 | -19,110 | -12,693 | -4,300 | -3,737 |
| Interest Expense | 13,790 | 6,461 | 1,356 | 598 | 73 |
| Other Income | 3,210 | -1,349 | -184 | 137 | 195 |
| Pre-tax Income | -27,808 | -26,920 | -14,233 | -4,761 | -3,615 |
| Income Tax | 0 | -1,174 | N/A | N/A | 0 |
| Net Income Continuous | -27,808 | -25,746 | -14,233 | -4,761 | -3,615 |
| Net Income | $-27,808 | $-25,746 | $-14,233 | $-4,761 | $-3,615 |
| EPS Basic Total Ops | -0.32 | -0.32 | -0.20 | -0.08 | -0.07 |
| EPS Basic Continuous Ops | -0.32 | -0.32 | -0.20 | -0.08 | -0.07 |
| EPS Diluted Total Ops | -0.32 | -0.32 | -0.20 | -0.08 | -0.07 |
| EPS Diluted Continuous Ops | -0.32 | -0.32 | -0.20 | -0.08 | -0.07 |
| EBITDA(a) | $-11,392 | $-19,041 | $-12,134 | $-3,739 | $-3,407 |